Literature DB >> 12163205

Cardiac cachexia in early literature: a review of research prior to Medline.

Wolfram Doehner1, Stefan D Anker.   

Abstract

Cachexia has been known to physicians since ancient Greek times as a 'signum mali ominis' in various diseases indicating end stage disease and poor quality of life. Cardiac cachexia is recently receiving growing attention as modern treatment options prevent early death from cardiac events and more patients live with chronic compensated heart failure. Nevertheless, observation and clinical documentation of this condition go back as long as medical science itself. Pioneering studies on the reasons and mechanisms of cachexia were performed several decades ago. These studies provide fundamental insights and guidance towards a better understanding of cachexia. This review presents an overview of early thoughts and milestone studies on metabolic abnormalities and cachexia in chronic heart failure.

Entities:  

Mesh:

Year:  2002        PMID: 12163205     DOI: 10.1016/s0167-5273(02)00230-9

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

Review 2.  Understanding of sarcopenia: from definition to therapeutic strategies.

Authors:  Jee Won Kim; Ryuni Kim; Hyerim Choi; Sang-Jin Lee; Gyu-Un Bae
Journal:  Arch Pharm Res       Date:  2021-09-18       Impact factor: 4.946

3.  Cachexia as a major underestimated and unmet medical need: facts and numbers.

Authors:  Stephan von Haehling; Stefan D Anker
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-10-26       Impact factor: 12.910

Review 4.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

Review 5.  [Obesity and cardiac cachexia in chronic heart failure].

Authors:  M Clauser; J Altenberger
Journal:  Herz       Date:  2013-09       Impact factor: 1.443

6.  Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure - is there only one cachexia?

Authors:  Tomislav Letilovic; Sonja Perkov; Zlata Flegar Mestric; Radovan Vrhovac
Journal:  Nutr J       Date:  2013-01-07       Impact factor: 3.271

7.  Leptin in anorexia and cachexia syndrome.

Authors:  Diana R Engineer; Jose M Garcia
Journal:  Int J Pept       Date:  2012-02-08

8.  Malnutrition and associated factors among heart failure patients on follow up at Jimma university specialized hospital, Ethiopia.

Authors:  Hiwot Amare; Leja Hamza; Henok Asefa
Journal:  BMC Cardiovasc Disord       Date:  2015-10-15       Impact factor: 2.298

Review 9.  Frailty, sarcopenia and cachexia in heart failure patients: Different clinical entities of the same painting.

Authors:  Matteo Beltrami; Carlo Fumagalli; Massimo Milli
Journal:  World J Cardiol       Date:  2021-01-26

10.  Estimating fat mass in heart failure patients.

Authors:  Tobias Daniel Trippel; Julian Lenk; Hanns-Christian Gunga; Wolfram Doehner; Stephan von Haehling; Goran Loncar; Frank Edelmann; Burkert Pieske; Alexander Stahn; Hans-Dirk Duengen
Journal:  Arch Med Sci Atheroscler Dis       Date:  2016-08-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.